Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
D031841:Aconitum / Q000037:antagonists & inhibitors; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001554:Benzene / Q000037:antagonists & inhibitors; D002122:Calcium Chloride / Q000037:antagonists & inhibitors; D004285:Dogs; D004558:Electric Stimulation; D004562:Electrocardiography; D004837:Epinephrine / Q000037:antagonists & inhibitors*; D005260:Female; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009025:Morpholines / Q000627:therapeutic use*; D009281:Naphthalenes / Q000627:therapeutic use*; D010042:Ouabain / Q000037:antagonists & inhibitors; D011342:Procainamide / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013610:Tachycardia / Q000139:chemically induced; D013974:Thyroxine / Q000037:antagonists & inhibitors; D014693:Ventricular Fibrillation / Q000139:chemically induced
D000889:Anti-Arrhythmia Agents; D009025:Morpholines; D009281:Naphthalenes; D010042:Ouabain; D011802:Quinidine; D001554:Benzene; D011342:Procainamide; D002122:Calcium Chloride; D013974:Thyroxine; D004837:Epinephrine